Home > Newsletters > FDAnews Drug Daily Bulletin > Authorized Generic Deals May Be a Thing of the Past, Lawyer Says
FDAnews Drug Daily Bulletin
July 20, 2012 | Vol. 9 No. 142
Authorized Generic Deals May Be a Thing of the Past, Lawyer Says
Drug companies’ patent settlements may no longer need clauses preventing authorized generic (AG) launches after Monday’s landmark court decision on pay-for-delay deals, a pharma lawyer says. Reverse settlements with side deals and other payments now will be presumed to be anticompetitive, Steve Maddox, partner with Knobbe Martens, said Wednesday.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.